A case of acquired von Willebrand syndrome successfully treated with recombinant Factor VIIa during thyroidectomy
Smaradottir, A.; Bona, R.
Thrombosis and Haemostasis 92(3): 666-667
2004
ISSN/ISBN: 0340-6245 PMID: 15457604 Document Number: 580367
Document emailed within 1 workday
Related Documents
Shamsi, T.Sultan.; Hossain, N.; Soomro, N.; Hasan, J.Ara.; Noorani, M.; Kazi, S.; Quraishy, M.Saeed.; Jameel, B.; Sultan, S.Tipu.; Haider, S. 2005: Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature Jpma. Journal of the Pakistan Medical Association 55(11): 512-515Rastegar-Lari, G.; Ajzenberg, N.; Ribba, A.S.; Vereycken-Holler, V.; Legendre, P.; Villoutreix, B.; Meyer, D.; Baruch, D. 2001: Defect of heparin binding in plasma and recombinant von Willebrand factor with type 2 von Willebrand disease mutations Thrombosis and Haemostasis 86(6): 1459-1465
Inbal, A.; Kornbrot, N.; Harrison, P.; Randi, A.M.; Sadler, J.E. 1993: Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor Thrombosis and Haemostasis 70(6): 1058-1062
Kam, C.M.; Vlasuk, G.P.; Smith, D.E.; Arcuri, K.E.; Powers, J.C. 1990: Thioester chromogenic substrates for human factor VIIa: substituted isocoumarins are inhibitors of factor VIIa and in vitro anticoagulants Thrombosis and Haemostasis 64(1): 133-137
Ewenstein, B.M. 2001: Continuous infusion of recombinant factor VIIa: continue or not? Thrombosis and Haemostasis 86(4): 942-944
Mazurier, C.; Meyer, D. 1996: Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease--results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH Thrombosis and Haemostasis 76(2): 270-274
Nicolaisen, E.M.; Hansen, L.L.; Poulsen, F.; Glazer, S.; Hedner, U. 1996: Immunological aspects of recombinant factor VIIa (rFVIIa) in clinical use Thrombosis and Haemostasis 76(2): 200-204
Dündaröz, R.; Akin, R.; Okutan, V.; Sarici, U.; Alpay, F.; Gökçay, E. 1997: Acquired cytomegalovirus infection in infants. a case successfully treated with ganciclovir Presse Medicale 26(21): 1000-1001
Hamaekers, A.E.W.; van Mook, W.N.K.A.; Offermans, J.P.M.; Marcus, M.A.E. 2006: Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage American Journal of Critical Care: An Official Publication American Association of Critical-Care Nurses 15(4): 399-401
Lazarev, A.F.; Rossokha, A.V.; Mamaev, A.N.; Khodorenko, S.A.; Mamaeva, I.V.; Nazarov, A.V.; Tsyvkina, L.P. 2012: Use of recombinant factor VIIa to reduce transfusional load in hemorrhaging patients after surgery for malignant tumors Voprosy Onkologii 58(4): 568-571
Tanchev, S.; Platikanov, V.; Markova, S.; Slavov, N.; Bogdanova, A.; Dimitrova, D. 2004: Use of recombinant factor VIIa for the control of massive bleeding caused by uterine hypotonia in post-placental period Akusherstvo i Ginekologiia 43(1): 16-20
Guillet, B.; Pinganaud, C.; Proulle, V.; Dreyfus, M.; Lambert, T. 2002: Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VIi Thrombosis and Haemostasis 88(4): 698-699
Seigne, T.D. 1971: A successfully treated case of Mendelson's syndrome Journal of the Irish Medical Association 64(406): 109-112
Brown, C.V.R.; Sowery, L.; Curry, E.; Valadka, A.B.; Glover, C.S.; Grabarkewitz, K.; Green, T.; Hail, S.; Admire, J. 2012: Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center American Surgeon 78(1): 57-60
Nishino, H.; Kojima, K.; Oshima, H.; Nakagawa, K.; Fumura, M.; Kikuchi, N. 2013: A case of pancreatic and duodenal fistula after total gastrectomy successfully treated with coagulation factor XIIi Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 2304-2306
McCarron, M.M.; Boettger, M.L.; Peck, J.J. 1982: A case of neuroleptic malignant syndrome successfully treated with amantadine Journal of Clinical Psychiatry 43(9): 381-382
Genova, V.; Baleva, M.; Nikolov, K. 1987: Factor VIIi (von Willebrand antigen) in patients with acquired thrombocytopathies Vutreshni Bolesti 26(2): 82-85
Ehira, N.; Kudoh, A.; Katagai, H.; Takazawa, T. 2002: A successfully treated case of aspiration pneumonia with adult respiratory distress syndrome and shock Masui. Japanese Journal of Anesthesiology 51(5): 535-538
Pruthi, R.K.; Mathew, P.; Valentino, L.A.; Sumner, M.J.; Seremetis, S.; Hoots, W.K. 2007: Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial Thrombosis and Haemostasis 98(4): 726-732
Van Vliet, H.H.D.M.; Kappers-Klunne, M.C.; Leebeek, F.W.G.; Michiels, J.J. 2008: PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thrombosis and Haemostasis 100(3): 462-468